Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

Cédric Mercier (1) , Laetitia Dahan (2) , L'Houcine Ouafik (3) , Nicolas André (4) , Joseph Ciccolini (3)

1 Medical Oncology Unit
2 Digestive Oncology
3 Transfer Oncology Laboratory
4 Paediatric Oncology Unit

Mots clés: Life Sciences

Cédric Mercier, Laetitia Dahan, L'Houcine Ouafik, Nicolas André, Joseph Ciccolini. Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. European Journal of Clinical Pharmacology, 2010, 66 (9), pp.959-960. ⟨10.1007/s00228-010-0859-5⟩. ⟨hal-00601561⟩